Effects of serum paraoxonase and paraoxonase phenotypic distribution on the parameters of first trimester screening (original ) (raw )Effects-of-serum-paraoxonase-and-paraoxonase-phenotypic-distribution-on-the-parameters-of-first-trimester-screening.pdf
Mehmet Ozen
View PDFchevron_right
Assessment of serum paraoxonase and arylesterase activities in early pregnancy failure
Harun Toy
Swiss Medical Weekly Official Journal of the Swiss Society of Infectious Diseases the Swiss Society of Internal Medicine the Swiss Society of Pneumology, 2009
View PDFchevron_right
The paraoxonase 1 activity and lipid levels in umbilical cord blood and maternal venous blood, and their relations according to birth weight
Esra Dilek
The European Research Journal, 2022
View PDFchevron_right
Longitudinal changes in serum paraoxonase-1 activity throughout normal pregnancy
Michelle Natalia
Clinical Chemistry and Laboratory Medicine, 2006
View PDFchevron_right
Paraoxonase gene polymorphism, serum lipid, and oxidized low-density lipoprotein in preeclampsia
Myung-Geol Pang
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2007
View PDFchevron_right
Association of L55M and Q192R Polymorphisms of Paraoxonase-1 Gene with Preeclampsia
minoo yaghmaei
Archives of Medical Research, 2011
View PDFchevron_right
Oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia
Melahat Dirican
Clinical Biochemistry, 2004
View PDFchevron_right
THE EVALUATION OF PARAOXONASE 1 ACTIVITY IN PATIENTS WITH GESTATIONAL DIABETES
Halit Akbaş
View PDFchevron_right
Paraoxonase 1 Gene Polymorphism (rs662) and Increased Risk of Idiopathic Foetal Growth Restriction
Basu Banerjee
Journal of Clinical and Diagnostic Research, 2017
View PDFchevron_right
Serum paraoxonase-1 activity in Egyptian premenopausal women with metabolic syndrome and its relation with recurrent pre-eclampsia risk
Eman Youness
Journal of Applied Pharmaceutical Science
View PDFchevron_right
Maternal–neonatal serum paraoxonase 1 activity in relation to the mode of delivery
Aris Antsaklis , George Partsinevelos
Clinical Biochemistry, 2006
View PDFchevron_right
OS090. Performance of candidate clinical and biochemical markers in screening early in pregnancy to detect women at high risk to develop preeclampsia
Marc Charland
Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health, 2012
View PDFchevron_right
First and Second-Trimester Maternal Serum Analytes for the Prediction of Adverse Pregnancy Outcomes
Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)
Journal of Obstetrics, Gynecology and Cancer Research, 2021
View PDFchevron_right
Association of M55L and Q192R polymorphisms of paraoxonase 1 gene (PON1) with recurrent pregnancy loss risk: A case–control study
mahboobeh nasiri
International Journal of Reproductive Biomedicine, 2021
View PDFchevron_right
Relationship between first trimester aneuploidy screening test serum analytes and placenta accreta
Burcu Barutcuoglu
The Journal of Maternal-Fetal & Neonatal Medicine, 2017
View PDFchevron_right
Distribution of Biochemical and Ultrasound Markers Values in the First Trimester Screening Program in Timisoara
Alina Onofriescu
Revista de Chimie
View PDFchevron_right
Mid-trimester maternal serum markers in predicting adverse pregnancy outcome
George Adonakis , Georgios Androutsopoulos
Clin Exp Obstet Gynecol, 2009
View PDFchevron_right
Comparison of measured concentration values of biochemical serum markers with two immunoassay systems in first trimester screening for fetal aneuploidy
Philipp Soergel
Archives of Gynecology and Obstetrics, 2012
View PDFchevron_right
Predictive values, relative risks, and overall benefits of high and low maternal serum α-fetoprotein screening in singleton pregnancies: New epidemiologic data
Hershel Jick
American Journal of Obstetrics and Gynecology, 1989
View PDFchevron_right
The Values of First-trimester Maternal Serum Markers in Predicting Poor Obstetric Outcomes
Gülşen Doğan Durdağ
Istanbul Medical Journal, 2019
View PDFchevron_right
First trimester screening with biochemical markers and ultrasound in relation to non-invasive prenatal testing (NIPT)
Alexander Scharf
Journal of Perinatal Medicine, 2021
View PDFchevron_right
There is no relationship between Paraoxonase serum level activity in women with endometriosis and the stage of the disease: an observational study
Caio Barbosa
Reproductive Health, 2013
View PDFchevron_right
Influence of gravidity and foetal gender on the value of screening variables in the first trimester of pregnancy
Tamara Illescas , Pluvio Coronado
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
View PDFchevron_right
Early gestational profiling of oxidative stress and angiogenic growth mediators as predictive, preventive and personalised (3P) medical approach to identify suboptimal health pregnant mothers likely to develop preeclampsia
Evans Asamoah
EPMA Journal, 2021
View PDFchevron_right
Association between serum paraoxonase and plasma nitric oxide in pre-eclampsia
Dilutpal Sharma
International Journal of Advances in Medicine, 2014
View PDFchevron_right